Smith & Nephew wins prestigious Galien Award for PICO Negative Pressure Wound Therapy innovation
Smith & Nephew, (LSE:SN, NYSE:SNN), the global medical technology business, has been awarded the 2016 French Galien Award for PICO; the novel single-use negative pressure wound therapy (NPWT) system. The Prix Galien acknowledges significant advances in pharmaceuticals and medical devices which deliver real improvements to human life. The prize, awarded in the Medical Disability Compensation and Return to Social Life category, rewards Smith & Nephew’s determination to improve the daily lives of patients and professionals with the management of wounds.
Managing Director of Smith & Nephew SAS (France), Bertrand L’Huillier, said: “Receiving the Galien Award is a huge honour and recognition of our contribution to medical research and ability to innovate. It is also a great encouragement to continue our investment to support healthcare professionals in their daily efforts to improve the lives of patients worldwide.”
Improving community healthcare and patient outcomes
Managing wounds, whether chronic, acute or post-surgical, has a significant impact to a patients’ quality of life as well as a financial impact on the health economy . Chronic wounds are often hard to heal, resulting in a cycle of pain, anxiety, frequent home visits and reduced quality of life. However, with the availability of the PICO system in the community, the lives of patients with wounds are significantly improvedi.
A study of 326 community based patients whom received PICO treatment for pressure ulcers, leg ulcers, diabetic foot ulcers, trauma wounds and dehisced surgical wounds, showed that prior to using PICO wound dressings were being changed four times a week . This fell to two dressing changes a week when using PICO, and to 1.8 times a week, on average, in the four-week follow-up period. Fewer dressing changes resulted in considerable cost savings; the total cost of care using PICO was three times less than the baseline .